Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 172.80
Open 181.90
Day range 181.90 183.30
52-week range 60.90 183.30
Off day high 0.00%
Off 52-week high 0.00%
Volume 2.00
Avg. volume (3M) 2.06K
Market cap —
EPS (TTM) 8.54
Forward P/E —
P/E ratio (TTM) 21.47
Dividend yield 0.63% (1.08)
Beta (5Y) 0.40
Shares outstanding 44.55M
Short interest —
Earnings date Aug 1, 2026 (est.)
Analyst target —
Profit margin 0.00%
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Headquarters Brussels, Belgium
Earnings
Next report: Sat, Aug 1, 2026 (estimated)
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .